All Type of News
Tylenol, completed product recovery…Approximately 500,000 products disposed
Jansen, “continue to pay refunds to customers through call centers
(Dailypharm)
Jansen Korea has completed the product recovery process of Tylenol for kids. The return and abandoned amount of product accumulates ...
Yuhan, ‘TWYNSTA’ for 56.2 billion and ‘TRAJENTA’ for 39.9 billion
Major thirteen products 3Q sales accumulates to 265.9 billion…Acquired products promoted sales growth
(Medipana)
Yuhan’s newly acquired products are marching without hesitation.
Yuhan announced its projected t...
Yuhan "Sales volume" and Daewoong "profit"
Major pharmaceutical companies had the good 3rd quarter of this year at Sales and Sales profits, #1 sales Green Cross
(The Yakup Shinmoon)
Among top players, Yuhan continues to grow in sales, and Daewoong shows he...
Wholesale businesses; worsen profitability due to increasing of drug co marketing
After large-scale lump-sum drug price reduction, Multinational and local companies co marketing active but distribution margin reduced
(The Yakup Shinmoon)
Wholesales businesses oppose strongly against low margin...
KPA "opposing the changing plan against current Patient paid CARE BY PHYSICIAN OF CHOICE which deman
KPA( Korea Hospital Association) "opposing the changing plan against current Patient paid CARE BY PHYSICIAN OF CHOICE which demands of hospital sacrifice.
Jang Ho Geun, Director of insurance at KHA(Korean Hospital A...
"Exforge" Generics battle field Fall Scientific Conference of The Korean Society of Hypertension
Some Exforge generics set a 3-4 booths --- participation is not active yet
(The Korean Doctors weekly)
Reflecting Hypertension drug market Warring States period , All related major pharmaceutical companies have ...
"Opposing of Telemedicine Law" medical community power rush rally
KMA hearing from Physician association of city and province, and medicine affiliated organization. "Healthcare system chaos" a powerful struggle notice
(Doctor’s News)
Medical profession is being upsurge anti-gove...
KPMA to hold forum for cash reward system
The Korea Pharmaceutical Manufacturers Association (KPMA) said Thursday it will hold a two-hour forum on Nov. 6 on the re-implementation of the contentious cash reward system for doctors and pharmacists at its hall in...
Biosimilar Remsima comparable to Remicade in RA crossover study
Korean biotechnology company Celltrion presented results of its crossover trial for its biosimilar Remsima (infliximab candidate) at the American College of Rheumatology (ACR) 2013 Conference, which was held in San Di...
Concerns growing over remote medical care by smartphone
The Ministry of Health and Welfare said Tuesday it will allow doctors to perform remote-patient monitoring and treatment via telecommunications technology in 2015 to extend care to patients in far-flung areas, while p...
